Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models

MLA

Sheeba Jacob, et al. “Genomic Screening Reveals Ubiquitin-like Modifier Activating Enzyme 1 as a Potent and Druggable Target in c-MYC-High Triple Negative Breast Cancer Models.” PNAS Nexus, vol. 1, Oct. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ebdd1723650544a3719525301f2b58c&authtype=sso&custid=ns315887.

APA

Sheeba Jacob, Tia H Turner, Jinyang Cai, Konstantinos V Floros, Ann K Yu, Colin M Coon, Rishabh Khatri, Mohammad A Alzubi, Charles T Jakubik, Ynes M Bouck, Madhavi Puchalapalli, Mayuri Shende, Mikhail G Dozmorov, Sosipatros A Boikos, Bin Hu, J Chuck Harrell, Cyril H Benes, Jennifer E Koblinski, Carlotta Costa, & Anthony C Faber. (2022). Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models. PNAS Nexus, 1.

Chicago

Sheeba Jacob, Tia H Turner, Jinyang Cai, Konstantinos V Floros, Ann K Yu, Colin M Coon, Rishabh Khatri, et al. 2022. “Genomic Screening Reveals Ubiquitin-like Modifier Activating Enzyme 1 as a Potent and Druggable Target in c-MYC-High Triple Negative Breast Cancer Models.” PNAS Nexus 1 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ebdd1723650544a3719525301f2b58c&authtype=sso&custid=ns315887.